Literature DB >> 10593628

Comparison of generalized and localized hyperalgesia in patients with recurrent headache and fibromyalgia.

A Okifuji1, D C Turk, D A Marcus.   

Abstract

OBJECTIVES: Research suggests that dysregulated pain modulation may play an important role in recurrent headaches and fibromyalgia syndrome (FMS). The primary objective of this study was to investigate algesic responses in localized cervical and pericranial regions (ie, headache-specific areas) and distal locations (ie, trochanter and gluteal) in patients with primary headaches (tension-type and migraine). The headache patients' algesic responses were compared with those of a sample of patients with musculoskeletal pain who report generalized hyperalgesia, or FMS.
METHODS: Seventy patients with mixed headache diagnoses and 66 patients with FMS underwent a standardized examination of generalized hyperalgesia based on American College of Rheumatology criteria.
RESULTS: Twenty-eight of the 70 headache patients reported the presence of widespread TP pain, suggesting generalized hyperalgesia. Headache diagnosis was unrelated to the presence or absence of generalized hyperalgesia. The subset of headache patients with generalized hyperalgesia did not differ from the FMS patients in pain sensitivity in the cervical and pericranial areas. Regression analyses revealed that pressure pain sensitivity was significantly related to self-reported pain only in the headache patients with generalized hyperalgesia.
CONCLUSIONS: These results suggest that extensive dysregulation in pain modulation is important for a substantial minority of recurrent headache patients, who seem to be quite similar to FMS patients. Differential treatment planning targeting generalized hyperalgesia may be useful in treating headache patients exhibiting generalized hyperalgesia more effectively.

Entities:  

Mesh:

Year:  1999        PMID: 10593628     DOI: 10.1097/00006842-199911000-00009

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  12 in total

Review 1.  Evidence for shared pain mechanisms in osteoarthritis, low back pain, and fibromyalgia.

Authors:  Roland Staud
Journal:  Curr Rheumatol Rep       Date:  2011-12       Impact factor: 4.592

2.  A population-based twin study of functional somatic syndromes.

Authors:  K Kato; P F Sullivan; B Evengård; N L Pedersen
Journal:  Psychol Med       Date:  2008-06-26       Impact factor: 7.723

3.  Emotional modulation of pain and spinal nociception in fibromyalgia.

Authors:  Jamie L Rhudy; Jennifer L DelVentura; Ellen L Terry; Emily J Bartley; Ewa Olech; Shreela Palit; Kara L Kerr
Journal:  Pain       Date:  2013-03-19       Impact factor: 6.961

4.  Fibromyalgia and headache: an epidemiological study supporting migraine as part of the fibromyalgia syndrome.

Authors:  Dawn A Marcus; Cheryl Bernstein; Thomas E Rudy
Journal:  Clin Rheumatol       Date:  2005-05-18       Impact factor: 2.980

Review 5.  At the crossroads between tension-type headache and fibromyalgia.

Authors:  Marc E Lenaerts; Paul S Gill
Journal:  Curr Pain Headache Rep       Date:  2006-12

Review 6.  Fibromyalgia and other unexplained clinical conditions.

Authors:  L A Aaron; D Buchwald
Journal:  Curr Rheumatol Rep       Date:  2001-04       Impact factor: 4.592

Review 7.  Fibromyalgia: an overview.

Authors:  Diane Thompson; Louise Lettich; Junji Takeshita
Journal:  Curr Psychiatry Rep       Date:  2003-07       Impact factor: 5.285

8.  Migraine headaches in chronic fatigue syndrome (CFS): comparison of two prospective cross-sectional studies.

Authors:  Murugan K Ravindran; Yin Zheng; Christian Timbol; Samantha J Merck; James N Baraniuk
Journal:  BMC Neurol       Date:  2011-03-05       Impact factor: 2.474

9.  The prevalence of fibromyalgia in other chronic pain conditions.

Authors:  Muhammad B Yunus
Journal:  Pain Res Treat       Date:  2011-11-17

10.  Migraine in gulf war illness and chronic fatigue syndrome: prevalence, potential mechanisms, and evaluation.

Authors:  Rakib U Rayhan; Murugan K Ravindran; James N Baraniuk
Journal:  Front Physiol       Date:  2013-07-24       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.